Co-Authors
This is a "connection" page, showing publications co-authored by Jianghui Cai and Mi Tang.
Connection Strength
5.371
-
New evidences that discard the possible vertical transmission of SARS-CoV-2 during pregnancy. Med Clin (Engl Ed). 2021 May 21; 156(10):523.
Score: 0.945
-
Coronavirus disease 2019 in pregnancy. Int J Infect Dis. 2021 04; 105:721.
Score: 0.934
-
Infection and thrombosis associated with COVID-19: Possible role of the ABO blood group. Med Clin (Barc). 2021 09 10; 157(5):e281.
Score: 0.926
-
New evidences that discard the possible vertical transmission of SARS-CoV-2 during pregnancy. Med Clin (Barc). 2021 05 21; 156(10):523.
Score: 0.912
-
Letter to the editor regarding the article: vertical transmission of SARS-CoV-2: a systematic review. J Matern Fetal Neonatal Med. 2021 Sep 01; 1.
Score: 0.241
-
Comment on "Current evidence of SARS-CoV-2 vertical transmission: an integrative review". Rev Assoc Med Bras (1992). 2021; 67Suppl 1(Suppl 1):170-171.
Score: 0.239
-
Adverse reactions of drugs specifically used for treatment of SARS-CoV-2 infection. Med Clin (Engl Ed). 2021 Jun 11; 156(11):576.
Score: 0.237
-
COVID-19 among pregnant Chinese women: case series data on the safety of vaginal birth and breastfeeding. BJOG. 2021 09; 128(10):1711.
Score: 0.237
-
Comment on "COVID-19 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review of critically unwell children and the association with underlying comorbidities". Eur J Pediatr. 2021 10; 180(10):3251-3252.
Score: 0.234
-
Cesarean Section or Vaginal Delivery to Prevent Possible Vertical Transmission From a Pregnant Mother Confirmed With COVID-19 to a Neonate: A Systematic Review. Front Med (Lausanne). 2021; 8:634949.
Score: 0.232
-
Adverse reactions of drugs specifically used for treatment of SARS-CoV-2 infection. Med Clin (Barc). 2021 06 11; 156(11):576.
Score: 0.232